Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00119002 · ClinicalTrials.gov registry record · Phase 4
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
A Phase 4 study of Bronchiolitis, Viral, sponsored by University of Utah.
- Completed
- Registry status
- Phase 4
- Development phase
- 598
- Enrollment target
- 1
- Study location
NCT00119002: Completed Phase 4 study of Bronchiolitis, Viral, sponsored by University of Utah.
NCT00119002 is a Phase 4 study of Bronchiolitis, Viral that has completed, run by University of Utah. The registered enrollment target is 598 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00119002, a Phase 4 study of Bronchiolitis, Viral, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 598 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used at that center. No current standard therapy is withheld, and no additional tests or other treatments are part of the study.The primary hypothesis is that dexamethasone will be more effective than placebo in preventing hospital admission. The secondary hypotheses are that dexamethasone will decrease respiratory scores and possibly the duration of the disease when compared to placebo, and that dexamethasone will be as safe and as well tolerated as placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG dexamethasone
Study Locations (1)
Utah
- Primary Children's Medical Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-04 |
| Phase | Phase 4 |
What the finished NCT00119002 record still lists
NCT00119002 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (15% higher).
The record links to 1 condition, with Bronchiolitis, Viral appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00119002 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00119002 about?
NCT00119002 is a clinical study titled "The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis". This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used...
What is the current status of trial NCT00119002?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 598 participants. The study started on 2004-01. Estimated completion is 2006-04.
What conditions does trial NCT00119002 study?
This clinical trial studies the following conditions: Bronchiolitis, Viral.
What interventions are being tested in trial NCT00119002?
The interventions under investigation include: Placebo (DRUG), dexamethasone (DRUG).
Who is sponsoring clinical trial NCT00119002?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00119002 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiolitis, Viral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00119002's enrollment target sits among peer trials
598 147th of 2000 higher than 1,854 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia